Emerging precision therapeutics for pancreatic ductal adenocarcinoma: KRAS and beyond
Therapeutic Advances in Medical Oncology
Published online on April 27, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Pancreatic ductal adenocarcinoma (PDAC) remains a leading cause of cancer-related death with a rising incidence in younger individuals and no standard early detection exam. Kirsten rat sarcoma viral oncogene homolog (KRAS) is the most frequently mutated ...
Pancreatic ductal adenocarcinoma (PDAC) remains a leading cause of cancer-related death with a rising incidence in younger individuals and no standard early detection exam. Kirsten rat sarcoma viral oncogene homolog (KRAS) is the most frequently mutated ...